Aureobasidium.org

Review 2022

Aureobasidium spp. and their applications in biotechnology

Wang P., Jia S., Liu G., Chi Z., Zou X., Chi Z. · Process Biochemistry · DOI: 10.1016/j.procbio.2022.03.006
Read Original Paper DOI: 10.1016/j.procbio.2022.03.006
Research Archive
TL;DR — Key Findings
  • Aureobasidium species produce multiple enzymes and commercially relevant natural products.
  • The review covers genomes, biosynthetic pathways, and strain-engineering tools.
  • It is a biotechnology review, not a clinical health study.

Abstract

This review surveys the biotechnology of Aureobasidium species. It describes their ability to use varied substrates and produce enzymes and materials including pullulan, beta-glucan, polymalate, liamocins, siderophores, and melanin. The article also summarizes genome sequencing, whole-genome duplication in some strains, stress tolerance, biosynthetic pathways, and genetic tools for strain engineering. Its focus is the industrial and biological versatility of the genus. It does not test a health intervention and should not be treated as clinical evidence for an Aureobasidium-derived product.

Summary

Summary

Scope

A broad review of Aureobasidium genetics, metabolism, natural products, and industrial applications.

Interpretation

The article provides biotechnology context but no direct evidence of clinical efficacy or safety.

AI-generated summary for accessibility. Always refer to the original paper.

Citation

Wang P., Jia S., Liu G., Chi Z., Zou X., Chi Z.. Aureobasidium spp. and their applications in biotechnology. Process Biochemistry. 2022. DOI: 10.1016/j.procbio.2022.03.006.

Study Details
Study Type
Review
Published
2022
Journal
Process Biochemistry
Authors
Wang P., Jia S., Liu G., Chi Z., Zou X., Chi Z.
DOI
10.1016/j.procbio.2022.03.006
Access Full Paper
Read Original Paper Access via DOI
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.